Quality Assessment in Endoscopic Retrograde Cholangiopancreatography(ERCP)
NCT ID: NCT02698137
Last Updated: 2020-04-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1843 participants
OBSERVATIONAL
2016-03-31
2019-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Data will be prospectively reported using standard report forms and patients will be followed up to 30 days to detect late-onset complications.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cmplications of ERCP
NCT04062617
Prevalence and Predictive Factors of Difficult Biliary Cannulation
NCT06591364
A Register on the Quality of ERCP and Training of Endoscopists in Italy
NCT02971579
Primary Cholangioscopy Versus ERCP in the Diagnosis of Biliary Strictures
NCT04010734
Microbiological Assessment of Bile in Patients Undergone to Endoscopic Retrograde Cholangiography (ERCP): the "Microbile Registry"
NCT06115564
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All ERCPs in the participating centers will be documented using a standard report form which will require the attending endoscopist to provide data relating to the patient (age, gender, diagnosis, bilirubin levels) and the procedure (including but not limited to the indication, technical aspects including cannulation technique, time to cannulation, degree of trainee involvement - where appropriate, procedure-related adverse events and their outcome).
Because teaching ERCP is not yet a standardized procedure, we aim to assemble a large database, stemming from the experience of several teaching centers in order to identify the main patient and operator-related factors which might influence the outcome of the procedure.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Clinical Hospital Colentina
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
dr. Theodor Alexandru Voiosu
MD, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Theodor Voiosu, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Clinical Hospital Colentina
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
GI Endoscopy Unit, Department of Gastroenterology and Hepatology, University Hospital Zagreb
Zagreb, , Croatia
Endoscopia Digestiva Chirurgica, Policlinico Gemelli
Roma, , Italy
Gastroenterology Department, Colentina Hospital
Bucharest, , Romania
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Voiosu TA, Bengus A, Haidar A, Rimbas M, Zlate A, Balanescu P, Voiosu A, Voiosu R, Mateescu B. Antibiotic Prophylaxis Prior to Elective ERCP Does Not Alter Cholangitis Rates or Shorten Hospital Stay: Results of an Observational Prospective Study of 138 Consecutive ERCPS. Maedica (Bucur). 2014 Dec;9(4):328-32.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
QUASIE2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.